FINVX | HFYYX | FINVX / HFYYX | |
Total Expense Ratio | 0.01 | 0.86 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 0.86 | 1% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 23.909 | 19.544 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.5B | 2.28B | 681% |
Annual Yield % from dividends | 3.95 | 2.64 | 150% |
Returns for 1 year | 21.08 | 17.79 | 118% |
Returns for 3 years | 56.10 | 34.84 | 161% |
Returns for 5 years | 134.87 | 86.40 | 156% |
Returns for 10 years | 80.10 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VWYGX | 37.55 | -0.02 | -0.05% |
Voya Small Cap Growth C | |||
JNGLX | 63.56 | -0.08 | -0.13% |
Janus Henderson Global Life Sciences D | |||
RYWCX | 37.06 | -0.10 | -0.27% |
Rydex S&P SmallCap 600 Pure Growth C | |||
AIBBX | 14.19 | -0.07 | -0.49% |
Aristotle Small Cap Equity I-2 | |||
DNLDX | 58.82 | -0.30 | -0.51% |
BNY Mellon Active MidCap A |